Abstract
A new series of metronidazole derivatives containing piperazine rings were prepared via the reaction of 2-(2-methyl-5-nitro-1H-imidazol-1-yl)acetyl chloride with selected substituted piperazines in the presence of a base. Structures of the new compounds were confirmed by NMR and MS spectral data and by elemental analyses. The antibacterial and anti-parasitic activities of these compounds were evaluated in vitro. Some of the newly synthesized compounds exhibited superior activity against Clostridium sporogenes bacteria compared to the standard drug metronidazole. On the other hand, other derivatives exhibited remarkable antigiardial activity and were found to be more active than metronidazole with IC 50 ranging from 1.8 to 6.7 µg/dm3. 1-Ethyl-4-[2-(2-methyl-5-nitro-1H-imidazol-1-yl)ethyl]piperazine also exhibited antigiardial activity with similar IC 50 value (7.6 µg/cm3) as compared to the reference drug metronidazole (IC 50 = 7.4 µg/cm3). Similarly, several of the new compounds exhibited significant antitrichomonal activity and found to be more active than metronidazole with IC 50 ranging from 6.7 to 8.65 µg/cm3 as compared to the reference drug metronidazole (8.9 µg/cm3).
Graphical abstract
Similar content being viewed by others
References
Upcroft P, Upcroft JA (2001) Clin Microbiol Rev 14:150
Çelik A, Ates NA (2006) Drug Chem Toxicol 29:85
Elkhoudary M, Abdel Salam R, Hadad G (2014) Spectrochim Acta A 130:222
Trevor AJ, Katzung B, Masters S (2009) Basic and clinical pharmacology, 11th edn. McGraw Hill Medical Publishing Division, p 1064
Busatti H, Alves R, Santana-Anjos K, Gil F, Cury M, Vannier-Santos M, Gomes M (2013) Diagn Micr Infec Dis 75:160
Bucklin MH, Groth CM, Henriksen B (2014). In: Wexler P (ed), Encyclopedia of toxicology, 3rd edn. Academic Press, p 330
Olender D, Zwawiak J, Lukianchuk V, Lesyk R, Kropacz A, Fojutowski A, Zaprutko L (2009) Eur J Med Chem 44:645
Samuelson J (1999) Antimicrob Agents Chemother 43:1533
Brogan O, Garnett PA, Brown R (1989) J Antimicrob Chemother 23:660
Silvestri R, Artico M, Massa S, Marceddu T, Montis F, Colla L (2000) Bioorg Med Chem Lett 10:253
Günay NS, Çapan G, Ulusoy N, Ergenç N, Ötük G, Kaya D (1999) Il Farmaco 54:826
Bender J, Meanwell N, Wang T (2002) Tetrahedron 58:3111
Kaiser C, Audia VH, Carter JP, Macpherson DW, Waid PP, Lowe VC, Noronha-Blob L (1993) J Med Chem 36:610
Vincent L (1990) In: Lee VHL (ed) Peptide and protein drug delivery. Marcel Dekker Inc, New York, p 167
Yildiz-Oren I, Aki-Sener E, Ertas C, Temiz-Arpaci O, Yalci I, Altanlar N (2004) Turk J Chem 28:441
Boonen J, Bronselaer A, Nielandt J, Veryser L, De Tré G, De Spiegeleer B (2012) J Ethnopharmacol 142:563
Saadeh HA, Mosleh IM, Al-Bakri AG, Mubarak MS (2010) Monatsh Chem 141:471
Saadeh HA, Mosleh IM, Mubarak MS (2009) Molecules 14:1483
Abu-Shairah EAM, Saadeh HAM, Mosleh IMI, Al-Arif MTA, Mubarak MSHM (2009) Preparation of metronidazole derivatives as antiparasitic agents. European Patent EP 2085394. Chem Abstr 151:221174
Al-Zghoul KH, Salih KSM, Ayoub MT, Mubarak MS (2005) Heterocycles 65:2937
Mirzaei J, Amini M, Pirelahi H, Shafiee A (2008) J Heterocycl Chem 45:921
Krashin JW, Koumann EH, Bradshaw-Sydnor AC, Braxton JR, Evan SW, Sawyer MK, Markowitz LE (2010) Sex Trans Dis 37:440
Methods for antimicrobial susceptibility testing of anaerobic bacteria. Approved standard, 8th edn; CLSI document M11-A8 (2012). Clinical and Laboratory Standards Institute, Wayne
Diamond LS (1957) J Parasitol 43:488
Keister DB (1983) Trans R Soc Trop Med Hyg 77:487
Naidoo D, van Vuuren SF, van Zyl RL, de Wet H (2013) J Ethnopharmacol 149:656
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Al-Qtaitat, M.A., Saadeh, H.A., Al-Bakri, A.G. et al. Synthesis, characterization, and biological activity of novel metronidazole-piperazine amides. Monatsh Chem 146, 705–712 (2015). https://doi.org/10.1007/s00706-014-1352-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00706-014-1352-0